ライフサイエンスコーパス: hepatic lesion

1 d immunophenotypical features as the primary hepatic lesion.

2 surgical resection of the primary tumor and hepatic lesions.

3 erpreted together, 869 (74%) patients had no hepatic lesions.

4 the formation of the base modifications and hepatic lesions.

5 hocytes were found in close association with hepatic lesions.

6 MR images in 133 patients with proved focal hepatic lesions (95 benign, 38 malignant).

7 8 treatment had no effect on the severity of hepatic lesions and caused a significant increase in ser

8 Altogether, our results indicate that both hepatic lesions and elevated serum IgE concentrations in

9 hagocytophilum-infected mice had more severe hepatic lesions and increased apoptosis.

10 tion has been restricted to the diagnosis of hepatic lesions and lymph node metastasis but functional

11 generation of a new mouse model to study the hepatic lesions associated with polycystic kidney diseas

12 or number (P = .30) of small hypoattenuating hepatic lesions at initial CT and the subsequent develop

13 e, size, and number of small hypoattenuating hepatic lesions at initial CT and the subsequent develop

14 (15 mm or less in diameter) hypoattenuating hepatic lesions at initial CT.

15 lymph nodes, 120 pulmonary lesions, and 120 hepatic lesions, categorized by size and margin sharpnes

16 o definite liver metastasis and at least one hepatic lesion considered TSTC, reports of follow-up ima

17 The presence of at least one hepatic lesion deemed TSTC was reported in 277 of 941 wo

18 92.7%-96.9% of women with breast cancer and hepatic lesions deemed TSTC but no definite liver metast

19 The enlarging hepatic lesions deemed TSTC represented metastatic breas

20 Small hepatic lesions demonstrated interval growth in 44 (11.6

21 ges improves differentiation of small benign hepatic lesions from small malignant lesions.

22 regulated in all histological stages of HCV+ hepatic lesions, from minimal liver fibrosis to cirrhosi

23 tissues from 44 mice without characteristic hepatic lesions, H. hepaticus-specific DNA was amplified

24 In 21 patients with focal hepatic lesions, identical T2-weighted breath-hold fast

25 Small hepatic lesions in 303 (80.2%) patients demonstrated no

26 Small hepatic lesions in 31 (8.2%) patients were stable at fol

27 ts of SEA or CFA alone displayed the smaller hepatic lesions in a Th2-dominant environment typically

28 amatic acceleration, extent, and severity of hepatic lesions in c-myc/TGF-alpha mice clearly demonstr

29 We studied six hepatic lesions in immature, neoplasm-free English sole

30 setting, we first compared the intensity of hepatic lesions in IRF3-deficient versus wildtype mice.

31 ing in the detection and characterization of hepatic lesions in patients prior to surgery.

32 Although small hepatic lesions in patients with cancer more frequently

33 human HEV induced more severe and persistent hepatic lesions in pigs than did swine HEV.

34 nd number of aflatoxin-induced preneoplastic hepatic lesions in rats by >90%.

35 The appearance of hepatic lesions in the arterial phase of enhancement has

36 C (n = 40), and a spectrum of non-neoplastic hepatic lesions including normal liver and cirrhosis (n

37 Small hepatic lesions (lesions 1 cm or less in diameter or dee

38 Control animals showed no hepatic lesions nor immunoreactivity to TGF-beta 1.

39 The cell composition of early hepatic lesions of experimental murine tularemia has not

40 egenerative hyperplasia (NRH) is an uncommon hepatic lesion often associated with noncirrhotic portal

41 At this time in the development of hepatic lesions, only a relatively small number of micro

42 FDG PET clarified indeterminate hepatic lesions or identified additional distant metasta

43 Criteria for diagnosis included parenchymal hepatic lesions, positive cultures from liver aspirates

44 opment/progression of vascular invasion, new hepatic lesions) progression or (ii) extrahepatic (adren

45 re is no evidence that small hypoattenuating hepatic lesions seen at initial CT contribute to an incr

46 stopathologic evaluation of the 159 resected hepatic lesions served as the reference standard.

47 Indications for surgery for benign hepatic lesions should not be widened simply because the

48 The cases of hepatic lesions showed a TNR with respect to the tumor m

49 s), and TGF-beta 1 proteins in the different hepatic lesions suggests that TGF-beta isoforms may play

50 32-year-old woman with an asymptomatic 4 cm hepatic lesion that is radiologically indeterminate for

51 se patients also reportedly had other larger hepatic lesions that were interpreted as metastases.

52 calculi (28%), renal lesion/tumor (23%), and hepatic lesion/tumor (20%).

53 A subset of patients showing hepatic lesions was selected, and the TNR with respect t

54 The number and size of hepatic lesions were assessed.

55 Hepatic lesions were evaluated histologically and the di

56 n T2 relaxation times of the liver and focal hepatic lesions were lower on enhanced than on unenhance

57 ma and colorectal and breast cancers), small hepatic lesions were metastatic in 4%, 14%, and 22%, res

58 Small hepatic lesions were reported in 378 (12.7%) patients; 1

59 One or more small hypoattenuating hepatic lesions were seen at initial CT in 54 of 153 pat

60 CT images obtained in 69 patients with focal hepatic lesions were studied (35 consecutive cases and 3

61 Most frequently, hepatic lesions were the indication for additional imagi

62 shown that there is an early development of hepatic lesions where F. tularensis colocalizes with bot

63 atients known to have or suspected of having hepatic lesions who were eligible for surgery underwent

64 es, which increases the conspicuity of focal hepatic lesions with negligible reticuloendothelial cell